Breaking News - The Fly

Open Search

PHVS

Pharvaris

$

()

Pharvaris files automatic mixed securities shelf

PHVS

4/12/2024 - 16:22pm

Pharvaris price target raised by $1 at JMP Securities, here's why

PHVS

4/11/2024 - 06:12am

Pharvaris reports Q4 EPS (EUR 0.74) vs. (EUR 1.16) last year

PHVS

4/10/2024 - 16:15pm

Pharvaris appoints David Nassif as CFO

PHVS

4/10/2024 - 16:12pm

Pharvaris initiates RAPIDe-3, the Phase 3 clinical trial

PHVS

3/18/2024 - 06:51am

Pharvaris files to sell 5.55M ordinary shares for holders

PHVS

3/6/2024 - 16:42pm

Pharvaris' deucrictibant shows positive results in HAE attacks

PHVS

2/22/2024 - 07:14am

Pharvaris price target raised by $2 at BofA, here's why

PHVS , IONS , BCRX

1/23/2024 - 07:22am

Pharvaris price target raised by $9 at JMP Securities, here's why

PHVS

1/23/2024 - 06:06am

Morgan Stanley expects Pharvaris to be up 10-15% after FDA lifts clinical hold

PHVS

1/22/2024 - 08:20am

Pharvaris announces FDA lifting of clinical hold of deucrictibant in HAE attacks

PHVS

1/22/2024 - 06:52am

Pharvaris provides business update

PHVS

1/5/2024 - 06:54am

Pharvaris price target raised to $11 from $8 at BofA

PHVS

12/7/2023 - 09:15am

Pharvaris price target raised to $35 from $32 at Morgan Stanley

PHVS

12/7/2023 - 08:59am

Pharvaris 11.125M share Secondary priced at $24.00

PHVS

12/6/2023 - 07:09am